Advanced Research, LLC | Coral Springs, FL

Research site

(Unclaimed)

Location

6280 W. Sample Road #202, Coral Springs, Florida, United States of America

Site insights

Top conditions

Top treatments

Filgotinib

CT1812

Ritonavir

MEZIVd

Dexamethasone

Pertuzumab

RBM-007

Faricimab

Mezigdomide

PVd

Parent organization

This site is a part of Advanced Research, LLC

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

7 of 15 total trials

A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors

This is a dose-escalation and dose-expansion Phase 1/2a trial to evaluate the safety and tolerability of DB-1303/BNT323 in subjects with advanced sol...

Enrolling

HER2-positive Advanced Solid Tumor

Drug: Itraconazole

Biological: DB-1303/BNT323

A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy (SIENNA)

This study is researching experimental (study) drugs called pozelimab and cemdisiran. The study is focused on participants who have geographic atroph...

Enrolling

Age-related Macular Degeneration (AMD)

Geographic Atrophy (GA)

Drug: Placebo

Drug: Pozelimab

A Study of Efgartigimod PH20 SC Given by Prefilled Syringe in Adults with Thyroid Eye Disease (UplighTED)

This study aims to evaluate the efficacy, safety and tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and immunogenicity of efgartigimod P...

Enrolling

Thyroid Eye Disease

Other: Placebo PH20 SC

Combination Product: Efgartigimod PH20 SC

A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM) (SUCCESSOR-1)

The purpose of this study is to compare the efficacy and safety of mezigdomide (CC-92480), bortezomib and dexamethasone (MeziVd) versus pomalidomide,...

Enrolling

Relapsed or Refractory Multiple Myeloma

Drug: Pomalidomide

Drug: mezigdomide

Autologous Adipose-derived Stromal Vascular Fraction for Treatment of Knee Osteoarthritis

This study is a pivotal study to evaluate the efficacy and safety of a single injection of autologous adipose-derived SVF produced using the GID SVF-...

Active, not recruiting

Osteoarthritis, Knee

Device: GID SVF-2 Device System

Fluocinolone Acetonide Intravitreal Implant 0.18 mg in the Treatment of Chronic Non-Infectious Posterior Segment Uveitis

A study to evaluate the safety and efficacy of YUTIQ® 0.18 mg intravitreal implant for the management of chronic non-infectious posterior segment uve...

Active, not recruiting

Uveitis, Posterior

Drug: Fluocinolone Acetonide Intravitreal Implant 0.18 mg

Phase 2a to Evaluate PL-8177 in Subjects with Active Ulcerative Colitis (UC) (PL8177-205)

The purpose of this study is to compare PL8177 (a melanocortin receptor agonist) to placebo (in a 3:1 ratio-meaning that for every 3 people that get...

Active, not recruiting

Ulcerative Colitis Flare

Ulcerative

Drug: PL8177 Placebo

Drug: PL8177